Y-mAbs Therapeutics Inc. (YMAB)
4.64
-0.02 (-0.43%)
At close: Apr 04, 2025, 11:17 AM
13F Institute Ownership
Total Institutes of 113 in Y-mAbs Therapeutics expanded their positions with an increase of 5 investors compared to the previous quarter. An additional 3.02M shares, as total invested capital declined by $113.39M with ownership percentage increasing from 57.67% to 64.43%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.161
0.16
Call Flow 5,600
86%
Put Flow 900
14%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Paradigm Biocapital Advisors L... | 9.49% | 4.24M | +3.67% | 33.17M | 1.15% |
| Blackrock, Inc. | 6.72% | 3M | -0.88% | 23.48M | < 0.01% |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.